Cti Biopharma reported $134.53M in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Applied Genetic Technologies AGTC:US $ 87.19M 5.18M
Baxter International BAX:US $ 31831M 885M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Cti Biopharma CTIC:US $ 134.53M 3.1M
Cytori Therapeutics CYTX:US $ 21.27M 3.24M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Geron GERN:US $ 238.16M 39.74M
Mirati Therapeutics MRTX:US $ 1279.79M 141.51M
Northwest Biotherapeutics NWBO:US 27.52M 3.14M
Novartis NVS:US $ 122910M 2308M
Novartis NOVN:VX SF 122910M 2308M
Seattle Genetics SGEN:US $ 3630.34M 13.65M
Teva Pharmaceutical Industries TEVA:US $ 45932M 1127M
YTE INCY:US $ 5319.04M 264.81M